Lv5
910 积分 2021-01-16 加入
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
7个月前
已完结
Therapeutic developments in pancreatic cancer
7个月前
已完结
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
7个月前
已完结
Zimberelimab: First Approval
8个月前
已完结
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
8个月前
已完结
Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches
1年前
已完结
Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling
1年前
已完结
A single-arm, open-label, phase II study investigating anti-HER2 ADC plus anti-PD-1 antibody in patients with unresectable locally advanced or metastatic BTC with HER2 overexpression
1年前
已关闭
Immunoconjugates and bispecific antibodies: trends in therapeutic success and commercial focus
2年前
已完结
Prevalence and role of HER2 mutations in cancer
2年前
已完结
皖公网安备34019202002308
